These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10743271)

  • 61. Clinical relevance of intrahepatic hepatitis B virus DNA in HBsAg-negative HBcAb-positive patients undergoing hematopoietic stem cell transplantation for hematological malignancies.
    Picardi M; De Rosa G; Selleri C; Pane F; Rotoli B; Muretto P
    Transplantation; 2006 Jul; 82(1):141-2. PubMed ID: 16861957
    [No Abstract]   [Full Text] [Related]  

  • 62. Isolated hepatitis B surface antigenemia in an HIV-1-positive individual.
    Smith S; Mounzer K
    AIDS; 2014 Jun; 28(9):1375-6. PubMed ID: 24959966
    [No Abstract]   [Full Text] [Related]  

  • 63. Reverse seroconversion of hepatitis B in a haemodialysis patient.
    Freudiger H; Sitavanc R
    Nephrol Dial Transplant; 2004 Jan; 19(1):238-41. PubMed ID: 14671065
    [No Abstract]   [Full Text] [Related]  

  • 64. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers.
    Chen D; Kaplan L; Liu Q
    Clin Chim Acta; 2005 May; 355(1-2):41-5. PubMed ID: 15820476
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identifying a hepatitis B outbreak by molecular surveillance: a case study.
    Fisker N; Carlsen NL; Kolmos HJ; Tønning-Sørensen L; Høst A; Christensen PB
    BMJ; 2006 Feb; 332(7537):343-5. PubMed ID: 16470056
    [No Abstract]   [Full Text] [Related]  

  • 67. Transmission of hepatitis B virus from a vaccinated healthcare worker.
    Laurenson IF; Jones DG; Hallam NF; Saunders CJ; Fraser DM; Carman WF
    J Hosp Infect; 2007 Aug; 66(4):393-4. PubMed ID: 17602792
    [No Abstract]   [Full Text] [Related]  

  • 68. Does antibody to hepatitis B surface antigen protect renal transplant patients from hepatitis B?
    Huo TI; Wu JC
    J Gastroenterol Hepatol; 2004 Aug; 19(8):841-3. PubMed ID: 15242483
    [No Abstract]   [Full Text] [Related]  

  • 69. [Hepatitis B surface antigen and antibody positive rates of children and adolescents in Jeju].
    Seo JH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):304-14. PubMed ID: 14695697
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation.
    Hui CK; Yu J; Au WY; Zhang HY; Bartholomeusz A; Locarnini S; Kwong YL; Liang R; Lau GK
    J Clin Virol; 2005 Feb; 32(2):173-8. PubMed ID: 15653422
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
    Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatitis B and the dental profession.
    Mann JM
    N M Dent J; 1979 Aug; 30(2):14-7, 29-34. PubMed ID: 93272
    [No Abstract]   [Full Text] [Related]  

  • 76. The serology of hepatitis B.
    Hammond L
    Aust Fam Physician; 1987 Nov; 16(11):1698. PubMed ID: 3446154
    [No Abstract]   [Full Text] [Related]  

  • 77. [Clinico-immunological variants of acute hepatitis B].
    Ketiladze ES; Farber NA; Bugaeva NP
    Sov Med; 1980; (12):35-8. PubMed ID: 7221717
    [No Abstract]   [Full Text] [Related]  

  • 78. [The prevalence of the serological markers of the hepatitis B virus in a nonhospital population].
    Masqué J; Cano P; Ripoll J; García RM
    Aten Primaria; 1993 Jun; 12(2):119-20. PubMed ID: 8329545
    [No Abstract]   [Full Text] [Related]  

  • 79. [A comprehensive approach to the analysis of cytoimmunological indices in patients with viral hepatitis A and B].
    Kurilova VG; Lebedinskiĭ AP; Frolov AK; Monogarova NE
    Lik Sprava; 1992 Jul; (7):61-3. PubMed ID: 1333140
    [No Abstract]   [Full Text] [Related]  

  • 80. [The knowledge base of the Hepaxpert I System: automatic interpretation of Hepatitis A and B serology].
    Adlassnig KP; Horak W
    Leber Magen Darm; 1993 Dec; 23(6):251-60, 263-4, 267-6. PubMed ID: 8309341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.